4//SEC Filing
Sage Therapeutics, Inc. 4
Accession 0001562180-17-000574
CIK 0001597553operating
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 4:56 PM ET
Size
5.7 KB
Accession
0001562180-17-000574
Insider Transaction Report
Form 4
Anderson Thomas
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2017-02-06+40,000→ 40,000 totalExercise: $47.70Exp: 2027-02-06→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The securities awarded on 2/06/2017 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. Options to purchase 5,000 shares of common stock shall vest on the one year anniversary of the Vesting Start Date with 15,000 shares vesting in 36 equal monthly installments thereafter. Options to purchase 20,000 shares of common stock shall vest periodically over the next four years upon the Company achieving certain milestones.
Documents
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001597553
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 4:56 PM ET
- Size
- 5.7 KB